PubRank

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (POINT)

Clinical Trial ID NCT00991029

PubWeight™ 23.79‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00991029

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013 8.76
2 Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008 7.25
3 A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005 6.14
4 Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008 6.08
5 Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000 5.00
6 Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007 3.72
7 A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007 3.56
8 Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004 3.47
9 Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial. Circulation 2003 3.38
10 Very early risk of stroke after a first transient ischemic attack. Stroke 2003 3.26
11 Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007 3.19
12 Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990 3.15
13 Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med 2007 3.06
14 Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005 3.00
15 Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke 1999 2.39
16 The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology 2004 2.34
17 Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes. Circulation 2004 1.91
18 Stroke risk after transient ischemic attack in a population-based setting. Stroke 2004 1.88
19 Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison. Lancet Neurol 2009 1.87
20 Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005 1.67
21 Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol 2007 1.66
22 Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc 1973 1.59
23 An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke 2008 1.43
24 Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke 2013 1.29
25 Management and outcomes of transient ischemic attacks in Ontario. CMAJ 2004 1.27
26 Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials. Stroke 2012 1.23
27 Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 2004 1.22
28 Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J 2010 1.16
29 National study on emergency department visits for transient ischemic attack, 1992-2001. Acad Emerg Med 2006 1.13
30 Factors influencing the survival of 451 transient ischemic attack patients. Stroke 1987 1.05
31 Transient ischemic attacks in rural and urban northern Portugal: incidence and short-term prognosis. Stroke 2005 1.04
32 Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke 1998 1.03
33 Transient ischemic attacks and strokes with recovery prognosis and investigation. Stroke 1982 0.98
34 Short-term prognosis of stroke among patients diagnosed in the emergency department with a transient ischemic attack. Ann Emerg Med 2007 0.92
35 Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials. Int J Stroke 2013 0.90
36 Antiplatelet therapy in management of transient ischemic attack: overview and evidence-based rationale. J Emerg Med 2008 0.89
37 Greater Cincinnati/Northern Kentucky Stroke Study: volume of first-ever ischemic stroke among blacks in a population-based study. Stroke 2001 0.87
38 High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. Am Heart J 2008 0.86
39 Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol 2003 0.86
40 Transient ischemic attacks are more than "ministrokes". Stroke 2004 0.85
41 Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement. Thromb Haemost 2008 0.85
42 Short-term bleeding events observed with clopidogrel loading in acute ischemic stroke patients. J Stroke Cerebrovasc Dis 2013 0.84
43 A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study. Stroke 1989 0.84
44 Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke 2013 0.84
45 Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE. Neurology 2015 0.83
46 Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. Eur Heart J 2008 0.83
47 Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and cons. J Clin Neurol 2014 0.81
48 Transient ischaemic attacks: unstable, treatable, neglected. Lancet 2007 0.80
49 Absence of usefulness of ABCD score in the early risk of stroke of transient ischemic attack patients. Stroke 2007 0.80
50 Current status of antiplatelet agents to prevent stroke. Curr Neurol Neurosci Rep 2011 0.79
51 Combination aspirin and clopidogrel for secondary prevention of ischemic stroke. Curr Treat Options Cardiovasc Med 2013 0.78
52 Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients. J Thromb Thrombolysis 2008 0.77
53 Plasminogen activators and ischemic stroke: conditions for acute delivery. Semin Thromb Hemost 2013 0.77
54 Early stroke risk after a transient ischemic attack: can it be minimized? Stroke 2008 0.77
55 Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol 1985 0.77
56 Rapid intervention for TIA: a new standard emerges. Lancet Neurol 2007 0.75
57 Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials. Int J Stroke 2015 0.75
58 Transient ischaemic attacks: time to wake up. Heart 2007 0.75
59 Preventing stroke after transient ischemic attack. CMAJ 2011 0.75
60 Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack. J Am Heart Assoc 2016 0.75
61 Dual antiplatelet therapy for secondary stroke prevention: Use of clopidogrel and acetylsalicylic acid after noncardioembolic ischemic stroke. Can Fam Physician 2016 0.75
62 Interpretation of ESPRIT in the FASTER trial. Lancet Neurol 2008 0.75
63 Early recurrence of cerebrovascular events after transient ischaemic attack. Stroke 2005 0.75
64 Architecture design of a generic centralized adjudication module integrated in a web-based clinical trial management system. Clin Trials 2015 0.75
65 Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention. J Cell Mol Med 2010 0.75
66 Screen failure data in clinical trials: Are screening logs worth it? Clin Trials 2014 0.75
Next 100